At A Glance
Pharma marketers need privacy-first identity workflows that keep DTC and HCP paths separate while connecting activation and measurement. Experian’s pharma marketing playbook shows how brands can prepare audiences, coordinate approved destinations, and build measurement into the workflow so teams can connect media exposure to trusted outcomes.Pharma marketers need to build more meaningful relationships with patients (DTC), caregivers, and healthcare professionals (HCP) across a health journey that spans many channels, partners, and decision moments.
That creates an operational challenge. Data, activation, and measurement often sit with different vendors, each with its own rules, IDs, and handoffs. DTC and HCP campaigns need separate identity paths, but both still need to support the same brand objective. Pharma marketing teams need a clearer way to connect audience strategy, media exposure, and outcomes without adding risk or confusion. That starts with identity, not as a single system for every audience, but as a governed workflow that keeps DTC and HCP paths separate and coordinated.
In our pharma marketing playbook, “From onboarding to outcomes: The privacy-first independent identity workflow for pharma marketing,” we show pharma brands how to build privacy-first workflows that connect identity, activation, and measurement across the healthcare ecosystem.
From onboarding to outcomes
Pharma marketing teams need identity workflows that can support accurate audience creation, governed activation, and partner-enabled measurement without combining DTC and HCP identity paths.
Download our pharma marketing playbook to help your team:
- Plan DTC and HCP identity strategies with clearer separation
- Prepare audiences for activation across approved channels and partners
- Evaluate audience quality, usable reach, and governance
Here are three priorities pharma marketing teams can use to build more governed, measurable engagement.
1. Why should pharma marketers keep DTC and HCP identity workflows separate?
Pharma marketers should keep DTC and HCP identity workflows separate because each audience requires different data signals, activation paths, and measurement methods. Separate workflows give teams clearer governance controls while helping DTC and HCP campaigns support the same brand objective.
DTC and HCP campaigns often support the same brand objective, but they need separate ways to manage data, reach audiences, and measure results. That’s where identity plays a central role. It gives pharma teams a governed way to keep DTC and HCP data, activation, and measurement separate while coordinating both toward the same goal, like driving drug awareness and impacting prescribing behavior.
The missing layer in pharma marketing. Watch our Q&A
DTC activation depends on privacy-safe identity, which can include tokenization, aggregated audience logic, and non-clinical consumer context. This helps brands better understand patients and caregivers as people, not only as condition-defined audiences.
HCP activation depends on a different foundation. It may use signals such as National Provider Identifier (NPI), specialty, practice location, partner identifiers, and other verified attributes. When DTC and HCP workflows are treated as one system, you can create governance risk, weaken audience logic, and make measurement harder to defend. Keeping them separate gives teams clearer controls, audience planning, and a stronger way to show how both efforts support the same brand goal.
2. How can pharma marketing teams make audiences activation-ready with privacy-safe identity?
Pharma teams can make audiences activation-ready by translating fragmented inputs into governed audience workflows that can be matched, activated, separated, and measured. Privacy-safe identity helps prepare DTC and HCP audiences for approved channels and partners while maintaining the separation each workflow requires.
Privacy-safe identity helps prepare DTC and HCP audiences for approved channels and partners while maintaining the separation each workflow requires.
After separating DTC and HCP data, activation, and measurement, the next step is making each audience ready to use across approved channels and partners. Pharma audiences rarely start in a format that is ready for activation across platforms, publishers, and partners. Inputs may come from partner audiences, platform identifiers, CRM systems, privacy-safe consumer signals, HCP attributes, or partner-provided data.
Those inputs need to be translated into usable audiences through governed identity workflows. For DTC campaigns, activation readiness may include cohort construction, non-clinical enrichment, caregiver logic, tokenized matching, and exclusion rules. For HCP campaigns, it may include verified identity inputs such as NPI, specialty, practice location, and professional address.
A strong workflow answers four questions:
- Can the audience be matched accurately?
- Can it be activated across approved destinations?
- Can DTC and HCP separation be maintained?
- Can the audience connect back to verification and measurement?
When the answer is yes, pharma brands have a stronger foundation for audience quality, usable reach, and cross-channel activation.
3. Why should pharma marketers build measurement into the workflow from the start?
Pharma marketers should build measurement into the workflow from the start because campaign exposure needs to connect back to permitted identity frameworks and partner-held outcomes. Planning measurement before activation gives teams a clearer, more explainable way to evaluate how audience strategy, media exposure, and outcomes work together.
Making audiences ready for activation is only one part of the job. Pharma teams also need a clear way to connect media exposure to outcomes, and that measurement plan needs to be in place before a campaign goes live.
Pharma measurement requires more than knowing whether media ran. Brands need to connect exposure signals to permitted identity frameworks and partner-held outcomes in a way that is accurate, governed, and explainable. Those outcomes may include script lift, qualified HCP engagement, audience quality, and exposure-based HCP reporting where appropriate.
Clean rooms and partner-enabled workflows can help connect exposure, identity, and outcomes in a governed way. For DTC campaigns, this may involve linking tokenized audience or exposure data to a measurement partner environment. For HCP campaigns, this may involve resolving exposure back to HCP identity using NPI, professional address, specialty, practice location, partner identifiers, or measurement partner IDs.
When measurement is planned before activation begins, teams gain a clearer view of how audience strategy, media exposure, identity, and outcomes connect.
How does Experian help pharma marketing teams connect identity, activation, and measurement?
Experian helps pharma marketing teams connect identity, activation, and measurement by serving as a neutral, interoperable workflow layer across data, onboarding, approved destinations, and measurement partners. Experian helps teams keep DTC and HCP identity paths separate while preserving the connection between activation and outcomes. Our role centers on three practical needs. We help teams:
As a neutral, interoperable identity, data, and workflow layer, we help brands translate fragmented inputs into activation-ready audiences, connect those audiences to approved destinations, and preserve the structure needed to evaluate performance.
Download Experian’s pharma marketing playbook
These three priorities give pharma teams a place to start. Our full pharma marketing playbook goes deeper into how pharma brands can build privacy-first workflows across onboarding, activation, sequencing, and partner-enabled measurement. Inside the playbook, you’ll find a more detailed look at how to:
- Keep DTC and HCP identity strategies separate
- Prepare audiences for activation across channels
- Evaluate audience quality and governance
- Connect exposure to trusted outcomes through partner-enabled measurement
For pharma marketers working across fragmented data, platforms, and partner ecosystems, our playbook offers a framework for moving from fragmented inputs to more governed activation and stronger measurement readiness. Download our full playbook to learn how privacy-first identity workflows can help pharma brands connect onboarding, activation, and outcomes.
FAQs
Pharma marketers need separate DTC and HCP identity workflows because patients, caregivers, and healthcare professionals require different data signals, activation paths, and measurement methods. Keeping those paths separate helps teams maintain governance while coordinating both efforts toward the same brand objective.
Privacy-safe identity helps pharma marketers translate audience inputs into activation-ready audiences without treating DTC and HCP workflows as one system. It can support tokenized matching, cohort construction, verified HCP identity inputs, and the separation needed to connect activation with trusted outcomes.
Experian helps pharma brands connect data, identity, onboarding, activation, and measurement across a fragmented partner ecosystem. Experian’s identity foundation and workflow connectivity help teams prepare audiences for approved destinations while preserving the structure needed to evaluate trusted outcomes.
Measurement planning should happen before activation begins. When pharma teams define measurement early, they can connect audience strategy, media exposure, identity, and partner-held outcomes in a more accurate, governed, and explainable way.
Pharma marketers should look for audiences that can be matched accurately, activated across approved destinations, kept separate across DTC and HCP workflows, and connected back to verification and measurement. This gives teams a stronger foundation for audience quality, usable reach, and cross-channel activation.
Latest posts
Cross-screen marketing tech firm, Tapad, drove unified campaign; partnered with Statiq to measure cross-screen impact on in-store visits LONDON, March 8, 2016 /PRNewswire/ — Carat North completed the UK’s most comprehensive digital campaign with Tapad, the leader in cross-device marketing technology and now a part of Experian. Coupled with location-based audience data from Statiq, this marks the first time a UK-company has measured the impact of unified, cross-screen campaign on in-store visits. Carat North served display and video ads to grocery shoppers for the leading retailer ASDA from August through October. During the campaign, Tapad utilized Statiq’s audience data to measure which users visited a store after being exposed* to the campaign’s ad on multiple devices. The digital campaign demonstrated a lift of 59% for in-store visits when users were exposed to ads on three devices over people who were shown an ad only on onescreen. Those who engaged with the ad were also 411% more likely to visit an ASDA store. Of those who were exposed to an ad, 248% were more likely to visit a store. Impressions served to mobile devices saw the highest success rate with an in-store visit lift of 67%. The campaign leveraged Tapad’s proprietary technology, The Device Graph™, which Nielsen confirmed Tapad’s cross device accuracy to be 91.2%, to serve ads sequentially on connected devices belonging to the same user. CARAT NORTH: “The ability to know which devices belong to our customer, coupled with the ability to deliver the right ad, and right message, wherever they are and on whatever device they’re using, has been something this industry has long needed,” said Steve Thornton, Digital Account Manager, Carat North. “We’re impressed with the results that have come from the work with Tapad and Statiq for this media-first, and look forward to continuing to offer these solutions to clients like ASDA. Matching unified cross-device capabilities with real insights on campaign performance is an invaluable advantage in the marketing world.” TAPAD: “This campaign is a perfect example of the capabilities of cross-device advertising,” said Are Traasdahl, Founder and CEO, Tapad. “In addition to reaching users across devices, we’re able to analyze campaign results and determine how different combinations of ad exposure, creative type or view frequency affected their decision to visit a location.” STATIQ: “As a location data specialist, Tapad is our ideal partner – they are an industry leader and by working with them we are able to determine the impact unified messaging has on real world consumer behaviours,” said Dean Cussell, Co-Founder of Statiq. “We believe this type of analysis will significantly aid brands in optimising future ad spend.” About Carat North Carat North is a leading independent media planning & buying specialist in digital and non-traditional media solutions. Owned by global media group Dentsu Aegis Network, the Carat network is more than 6,700 people in 130 countries worldwide across 170 cities. Carat defined the sector when established as the world’s first media independent in 1968 and is now Europe’s largest media network, a position held for more than 15 years. For more information visit www.carat.co.uk About Tapad Tapad Inc. is a marketing technology firm renowned for its breakthrough, unified, cross-device solutions. With 91.2% data accuracy confirmed by Nielsen, the company offers the largest in-market opportunity for marketers and technologies to address the ever-evolving reality of media consumption on smartphones, tablets, home computers and smart TVs. Deployed by agency trading desks, publishers and numerous Fortune 500 brands, Tapad provides an accurate, unified approach to connecting with consumers across screens. In 2015, Tapad began aggressively licensing its identity management solution, the Tapad Device Graph™, and swiftly became the established gold-standard throughout the ad tech ecosystem. Tapad is based in New York and has offices in Atlanta, Boston, Chicago, Dallas, Detroit,Frankfurt, London, Los Angeles, Miami, Minneapolis, San Francisco and Toronto. TechCrunch called the powerhouse Tapad team “a hell of a list of entrepreneurs who created some of the most valuable online advertising companies of the last decade.” Among Tapad’s numerous awards: EY Entrepreneur of The Year (East Coast) 2014, among Forbes’ Most Promising Companies two year’s running, Deloitte’s Technology Fast 500, Crain’s Fast 50, Entrepreneur 360, Digiday Signal Award, iMedia ASPY Award, and a MarCom Gold Award. Read the full release here. *Tapad utilized Statiq’s audience data to measure which users visited a store during, or within one month of, being exposed to the campaign’s ad on multiple devices. Contact us today
Welcome emails garner 86 percent higher open rates than regular promotional mailings. What other life cycle marketing programs should you be running?
If information is accurate when collected, loyalty programs have a better chance at engaging consumers and actually seeing the benefit that a loyalty program can provide.